Examination of a pilot clinical trial testing a marine-derived multi-mineral supplement's effects on gut barrier function in ulcerative colitis patients.
Key Takeaways
- Aquamin supplementation reduced total post-intervention urinary mannitol excretion by 29%
- Aquamin was well tolerated with no serious adverse events reported
- 180-day trial reported reduced CRP, alkaline phosphatase, and fecal calprotectin